WPHM Comptes : Analyse IA Winston Pharmaceuticals Inc



Comptes financiers

WPHM Financier

Winston Pharmaceuticals Inc

À la fermeture : May 07, 16:00:00 GMT-4

Post-Marché: May 07, 20:00:00 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Statistiques clés

Clôture préc.

$0.0001

Prix d'ouverture

$0.0001

Plage de la journée

$0.0001 - $0.0001

Plage de 52 semaines

$0 - $0.0001

Volume

16.1K

Volume moyen

5.5K

Rendement en dividend

BPA (TTM)

-0.04

Capitalisation boursière

$7.7K

Qu’est-ce que WPHM ?

Winston Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the discovery and development of products for pain management. The company is headquartered in Vernon Hills, Illinois and currently employs 9 full-time employees. The company went IPO on 2006-02-23. The firm discovers, develops and commercializes therapeutics for managing and alleviating pain. The firm's late stage candidates include products for the treatment of episodic cluster headache, chronic migraine headache, osteoarthritis, rheumatoid arthritis, neuropathic pain, and pain and inflammation in inflammatory bowel disease. The firm is developing Civamide, which is a transient receptor potential channels vanilloid-1 (TRPV-1) modulator in different dosage forms for several different pain indications. The firm's other products are under development for the treatment of headache and neuropathic and rheumatological pain.

Fonctionnalités

Markets

News

Conditions d’utilisation Politique de confidentialité

Revenus

État de situation

Flux de trésorerie

Annuel

Trimestriellement

WPHM Revenu

Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.

Breakdown	TTM	03/31/2010	12/31/2009	09/30/2009	06/30/2009	03/31/2009
Revenus	1	0	0	0	0	0
Croissance des revenus (H/H)	--	--	--	--	--	--
Coût des ventes	--	--	--	--	--	--
Bénéfice brut	--	--	--	--	--	--
Vente, Général et Administration	1	0	0	0	0	0
Recherche et développement	1	0	0	0	0	0
Frais d'exploitation	3	0	0	1	1	1
Autres revenus (charges) non opérationnels	0	0	0	0	0	0
Bénéfice avant impôts	-2	0	0	0	0	0
Charge d'impôt sur le revenu	0	0	0	0	0	0
Bénéfice net	-2	0	0	0	0	0
Croissance du bénéfice net	-50%	--	-100%	-100%	-100%	-100%
Actions en circulation (diluées)	77.4	77.4	77.59	56.68	55.44	55.3
Variation des actions (H-H)	40%	40%	42%	7%	5%	5%
EPS (dilué)	-0.03	0	0	-0.01	-0.01	-0.01
Croissance du EPS	-56%	-56.99%	-64%	-38%	-63%	-53%
Flux de trésorerie libre	-3	0	0	0	-1	-1
Flux de trésorerie libre par action	--	--	--	--	--	--
Marge brute	--	--	--	--	--	--
Marge opérationnelle	-200%	0%	0%	0%	0%	0%
Marge bénéficiaire	-200%	0%	0%	0%	0%	0%
Marge du flux de trésorerie libre	-300%	0%	0%	0%	0%	0%
EBITDA	-2	0	0	0	0	0
Marge EBITDA	-200%	0%	0%	0%	0%	0%
D&A pour le résultat opérationnel	0	0	0	0	0	0
EBIT	-2	0	0	0	0	0
Marge EBIT	-200%	0%	0%	0%	0%	0%
Taux d'imposition effectif	0%	0%	0%	0%	0%	0%

Follow-Up Questions

Winston Pharmaceuticals Inc'in temel mali tabloları nelerdir?



Son mali tabloya (Form-10K) göre, Winston Pharmaceuticals Inc'in toplam varlıkları $0 olup, net perte $0'dir.

WPHM'ün temel finansal oranları nelerdir?



Winston Pharmaceuticals Inc'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.

Winston Pharmaceuticals Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?



Le segment de revenus le plus important est Winston Pharmaceuticals Inc, avec un chiffre d'affaires de Semiconductor & Electronics lors du dernier rapport de résultats. En termes géographiques, United States est le marché principal pour Winston Pharmaceuticals Inc, avec un chiffre d'affaires de 398,905,000,000.

Winston Pharmaceuticals Inc kârlı mı?



non, son mali tablolara göre Winston Pharmaceuticals Inc'in net perte $0'dir.

Winston Pharmaceuticals Inc'in herhangi bir yükümlülüğü var mı?



non, Winston Pharmaceuticals Inc'in yükümlülüğü 0'dir.

Winston Pharmaceuticals Inc'in tedavüldeki hisse sayısı kaçtır?



Winston Pharmaceuticals Inc'in toplam tedavüldeki hisse sayısı 0'dir.

Winston Pharmaceuticals Inc (WPHM) Financier

Graphique du cours de l'action WPHM